[
    [
        {
            "time": "2018-11-05",
            "original_text": "Top Insider Buys Highlight for the Week of Nov. 1",
            "features": {
                "keywords": [
                    "insider buys",
                    "highlight",
                    "week"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Top Insider Buys Highlight for the Week of Nov. 1",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-11-05",
            "original_text": "Eli Lilly CEO David Ricks and Other Insiders Are Buying the Slumping Stock",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "CEO",
                    "David Ricks",
                    "insiders",
                    "buying",
                    "slumping stock"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Eli Lilly CEO David Ricks and Other Insiders Are Buying the Slumping Stock",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]